News

Pharmabiz32m
Biodexa Pharma activates first clinical study site for phase 3 Serenta trial in familial adenomatous polyposis
Biodexa Pharma activates first clinical study site for phase 3 Serenta trial in familial adenomatous polyposis: United Kingdom Saturday, June 28, 2025, 15:00 Hrs [IST] Biodexa Pha ...
Pharmabiz1h
KalVista Pharma inks licensing agreement with Pendopharm to commercialize sebetralstat for HAE in Canada
KalVista Pharma inks licensing agreement with Pendopharm to commercialize sebetralstat for HAE in Canada: Cambridge, Massachusetts Saturday, June 28, 2025, 14:00 Hrs [IST] KalVist ...
Pharmabiz2h
US FDA approves label updates for Bristol Myers’ CAR T cell therapies, Breyanzi for LBCL & lymphomas and Abecma for multiple myeloma
US FDA approves label updates for Bristol Myers’ CAR T cell therapies, Breyanzi for LBCL & lymphomas and Abecma for multiple myeloma: Princeton, New Jersey Saturday, June 28, 20 ...
Pharmabiz4h
WHO issues alert on the use of semaglutide medicines and risk of non-arteritic anterior ischemic optic neuropathy
WHO issues alert on the use of semaglutide medicines and risk of non-arteritic anterior ischemic optic neuropathy: Geneva Saturday, June 28, 2025, 11:00 Hrs [IST] WHO is alerting ...
Pharmabiz3h
Bavarian Nordic initiates clinical trials of mpox vaccine in infants and pregnant women
Bavarian Nordic initiates clinical trials of mpox vaccine in infants and pregnant women: Copenhagen, Denmark Saturday, June 28, 2025, 12:00 Hrs [IST] Bavarian Nordic A/S, a global ...
Pharmabiz6h
European Commission approves Eylea 8 mg with extended 6-month treatment interval for nAMD and visual impairment due to DME
European Commission approves Eylea 8 mg with extended 6-month treatment interval for nAMD and visual impairment due to DME: Berlin Saturday, June 28, 2025, 09:00 Hrs [IST] The Eur ...
Pharmabiz7h
Centre makes application for WHO GMP & COPP mandatory through ONLDS portal from July 15
Centre makes application for WHO GMP & COPP mandatory through ONLDS portal from July 15: Gireesh Babu, New Delhi Saturday, June 28, 2025, 08:00 Hrs [IST] The Central drug regulato ...
Pharmabiz7h
Indian pharma speeds up access to global therapies while targeting treatment gaps
Indian pharma speeds up access to global therapies while targeting treatment gaps: Nandita Vijayasimha, Bengaluru Saturday, June 28, 2025, 08:00 Hrs [IST] Indian pharma is now agg ...
Pharmabiz7h
India’s digital health propels new era of integration and innovation
India’s digital health propels new era of integration and innovation: Nandita Vijayasimha, Bengaluru Saturday, June 28, 2025, 08:00 Hrs [IST] India’s digital health ecosystem ...
Pharmabiz7h
Experts discuss solutions in enhancing API manufacturing quality at USP Convention 2025
Experts discuss solutions in enhancing API manufacturing quality at USP Convention 2025: Shardul Nautiyal, Mumbai Saturday, June 28, 2025, 08:00 Hrs [IST] Experts discussed soluti ...
Pharmabiz7h
PCI clarifies that ranking and rating system is optional
The Pharmacy Council of India (PCI) has clarified that the registration and accreditation of the institutions offering undergraduate and Diploma in Pharmacy courses by the Quality Council of India ...
Pharmabiz7h
Centre may restrict distribution of anti-TB drugs through NTEP
Centre may restrict distribution of anti-TB drugs through NTEP: Our Bureau, New Delhi Saturday, June 28, 2025, 08:00 Hrs [IST] The Central government may soon restrict the distrib ...